002173 創新醫療
按盤價 
19.060 +0.510 (+2.749%)
19.060 +0.510 (+2.749%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -3.107 | -1.977 | -5.153 | -1.817 | -3.783 |
| 總資產報酬率 ROA (%) | -2.499 | -1.590 | -4.189 | -1.484 | -3.007 |
| 投入資產回報率 ROIC (%) | -2.813 | -1.805 | -4.771 | -1.691 | -3.430 | 邊際利潤分析 |
| 銷售毛利率 (%) | 1.439 | 6.909 | 7.805 | 11.446 | 4.310 |
| 營業利潤率 (%) | -15.811 | -3.913 | -7.394 | -3.183 | -11.075 |
| 息稅前利潤/營業總收入 (%) | -16.115 | -3.621 | -12.666 | -5.917 | -12.053 |
| 淨利潤/營業總收入 (%) | -16.194 | -4.641 | -11.518 | -4.256 | -10.370 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 104.560 | 247.944 | 59.321 | 65.472 | 112.334 |
| 價值變動淨收益/利潤總額(%) | -2.867 | -127.848 | -1.968 | 5.257 | -4.524 |
| 營業外收支淨額/利潤總額(%) | 1.956 | -5.831 | 40.047 | 26.670 | -4.410 | 償債能力分析 |
| 流動比率 (X) | 1.852 | 1.838 | 1.864 | 2.253 | 2.394 |
| 速動比率 (X) | 1.747 | 1.715 | 1.734 | 2.124 | 2.241 |
| 資產負債率 (%) | 18.886 | 19.031 | 19.367 | 17.988 | 18.577 |
| 帶息債務/全部投入資本 (%) | 5.341 | 3.366 | 3.206 | 2.375 | 1.823 |
| 股東權益/帶息債務 (%) | 1,687.949 | 2,700.534 | 2,861.630 | 3,931.377 | 5,086.934 |
| 股東權益/負債合計 (%) | 426.445 | 421.968 | 416.119 | 455.706 | 438.085 |
| 利息保障倍數 (X) | -1,431.269 | -47.339 | 37.968 | 3.753 | 8.336 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 40.780 | 49.278 | 50.078 | 34.499 | 34.219 |
| 存貨周轉天數 (天) | 18.491 | 19.383 | 20.053 | 22.976 | 24.463 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 20/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
